Kairos Pharma, Ltd. (KAPA)
NYSEAMERICAN: KAPA · Real-Time Price · USD
0.4401
+0.0001 (0.02%)
At close: Jun 15, 2026, 4:00 PM EDT
0.4401
0.00 (0.00%)
After-hours: Jun 15, 2026, 4:10 PM EDT
Kairos Pharma Market Cap
Kairos Pharma has a market cap or net worth of $9.42 million as of June 15, 2026. Its market cap has decreased by -8.32% in one year.
Market Cap
9.42M
Enterprise Value
5.81M
1-Year Change
-8.32%
Ranking
Category
Stock Price
$0.44
Market Cap Chart
Since the IPO on September 16, 2024, Kairos Pharma's market cap has decreased from $33.39M to $9.42M, a decrease of -71.78%. That is a compound annual growth rate of -51.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 15, 2026 | 9.42M | -36.26% |
| Dec 31, 2025 | 14.78M | -24.29% |
| Dec 31, 2024 | 19.53M | -41.52% |
| Sep 16, 2024 | 33.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Lunai Bioworks | 10.93M |
| Jupiter Neurosciences | 10.39M |
| BioCardia | 10.01M |
| Intensity Therapeutics | 9.59M |
| HCW Biologics | 9.17M |
| Curanex Pharmaceuticals | 9.11M |
| MetaVia | 8.99M |
| BioRestorative Therapies | 8.98M |